Seeking Alpha

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the ...
WSPA

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...
Nasdaq

Tactile Systems (TCMD) Q2 Revenue Up 8%

Tactile Systems Technology develops and sells medical devices for patients with lymphedema, a condition causing swelling due to lymphatic system issues, and for those needing help with airway ...
Nasdaq

Tactile Systems Reveals Positive Quality Of Life Endpoints For Flexitouch Device In Veterans

(RTTNews) - Tactile Systems Technology, Inc. (TCMD), Wednesday announced positive disease-specific health-related quality of life endpoints in a study of Flexitouch advanced pneumatic compression ...
Seeking Alpha

Tactile Systems Technology, Inc. (TCMD) CEO Gerald Mattys on Q4 2018 Results - Earnings Call Transcript

Please standby. Good afternoon, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2018 Earnings Conference Call for Tactile Medical. [Operator Instructions]. Please note that ...